![Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer - Kim - 2016 - Cancer Science - Wiley Online Library Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer - Kim - 2016 - Cancer Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/eaebccc3-1fa4-459d-ab15-db40480c2b5b/cas12987-fig-0001-m.jpg)
Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer - Kim - 2016 - Cancer Science - Wiley Online Library
![Surgical Management of Peritoneal Metastases from Colorectal Cancer Lower Gastrointestinal Cancer - GMKA - Global Medical Knowledge Alliance Surgical Management of Peritoneal Metastases from Colorectal Cancer Lower Gastrointestinal Cancer - GMKA - Global Medical Knowledge Alliance](https://gmka.org/wp-content/uploads/2023/01/Depositphotos_153325578_S.jpg)
Surgical Management of Peritoneal Metastases from Colorectal Cancer Lower Gastrointestinal Cancer - GMKA - Global Medical Knowledge Alliance
![Cancers | Free Full-Text | Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response Cancers | Free Full-Text | Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response](https://www.mdpi.com/cancers/cancers-13-04318/article_deploy/html/images/cancers-13-04318-g001-550.jpg)
Cancers | Free Full-Text | Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response
JAMA - Ascites, or excess abdominal fluid, is common in patients with liver disease and cirrhosis, and those with cancer. Cancer can spread to the lining of the organs—the peritoneum—and make it
![Malignant Ascites Treatment Market Size will Grow Profitably in the Near Future | CMI Study | Medgadget Malignant Ascites Treatment Market Size will Grow Profitably in the Near Future | CMI Study | Medgadget](https://www.medgadget.com/wp-content/uploads/2021/09/malignant-ascites-treatment-market.jpg)
Malignant Ascites Treatment Market Size will Grow Profitably in the Near Future | CMI Study | Medgadget
![Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research | Nature Reviews Cancer Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research | Nature Reviews Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrc3432/MediaObjects/41568_2013_Article_BFnrc3432_Fig1_HTML.jpg)
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research | Nature Reviews Cancer
![Ascites do not affect the rate of complete cytoreductive surgery and prognosis in patients with primary ovarian cancer with ascites treated with hyperthermic intraperitoneal chemotherapy Ascites do not affect the rate of complete cytoreductive surgery and prognosis in patients with primary ovarian cancer with ascites treated with hyperthermic intraperitoneal chemotherapy](https://www.spandidos-publications.com/article_images/ol/18/2/ol-18-02-2025-g00.jpg)
Ascites do not affect the rate of complete cytoreductive surgery and prognosis in patients with primary ovarian cancer with ascites treated with hyperthermic intraperitoneal chemotherapy
![A large-scale multi-institutional study evaluating prognostic aspects of positive ascites cytology and effects of therapeutic interventions in epithelial ovarian cancer | Scientific Reports A large-scale multi-institutional study evaluating prognostic aspects of positive ascites cytology and effects of therapeutic interventions in epithelial ovarian cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-93718-3/MediaObjects/41598_2021_93718_Fig1_HTML.png)
A large-scale multi-institutional study evaluating prognostic aspects of positive ascites cytology and effects of therapeutic interventions in epithelial ovarian cancer | Scientific Reports
![Current status and future directions: management of colon cancer with peritoneal dissemination | Future Oncology Current status and future directions: management of colon cancer with peritoneal dissemination | Future Oncology](https://www.futuremedicine.com/cms/10.2217/14796694.4.5.671/asset/images/medium/graphic15.gif)
Current status and future directions: management of colon cancer with peritoneal dissemination | Future Oncology
![Pattern and prognostic factors in patients with malignant ascites: a retrospective study - ScienceDirect Pattern and prognostic factors in patients with malignant ascites: a retrospective study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419420206-gr1.jpg)
Pattern and prognostic factors in patients with malignant ascites: a retrospective study - ScienceDirect
![Pattern and prognostic factors in patients with malignant ascites: a retrospective study - ScienceDirect Pattern and prognostic factors in patients with malignant ascites: a retrospective study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419420206-gr3.jpg)
Pattern and prognostic factors in patients with malignant ascites: a retrospective study - ScienceDirect
![HIPEC OVHIPEC PMP peritoneal cancer peritoneum seeding seedings metastases hyperthermic intraperitoneal chemotherapy debulking colon colorectal ovarian ovary mesothelioma pseudomyxoma appendix HIPEC OVHIPEC PMP peritoneal cancer peritoneum seeding seedings metastases hyperthermic intraperitoneal chemotherapy debulking colon colorectal ovarian ovary mesothelioma pseudomyxoma appendix](https://drmulier.com/hipec%20en%201.jpg)
HIPEC OVHIPEC PMP peritoneal cancer peritoneum seeding seedings metastases hyperthermic intraperitoneal chemotherapy debulking colon colorectal ovarian ovary mesothelioma pseudomyxoma appendix
![Malignancy-related ascites in palliative care units: prognostic factor analysis | BMJ Supportive & Palliative Care Malignancy-related ascites in palliative care units: prognostic factor analysis | BMJ Supportive & Palliative Care](https://spcare.bmj.com/content/bmjspcare/early/2023/04/19/spcare-2023-004286/F2.large.jpg)
Malignancy-related ascites in palliative care units: prognostic factor analysis | BMJ Supportive & Palliative Care
![The untapped potential of ascites in ovarian cancer research and treatment | British Journal of Cancer The untapped potential of ascites in ovarian cancer research and treatment | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-020-0875-x/MediaObjects/41416_2020_875_Fig1_HTML.png)
The untapped potential of ascites in ovarian cancer research and treatment | British Journal of Cancer
![Frontiers | Malignant ascites in pancreatic cancer: Pathophysiology, diagnosis, molecular characterization, and therapeutic strategies Frontiers | Malignant ascites in pancreatic cancer: Pathophysiology, diagnosis, molecular characterization, and therapeutic strategies](https://www.frontiersin.org/files/MyHome%20Article%20Library/1138759/1138759_Thumb_400.jpg)